EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections.
EnteroBiotix has raised $25.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2026.
EnteroBiotix's investors include Scottish Enterprise, University of Aberdeen, Scottish National Investment Bank, SIS Ventures, Fund Twenty8.
EnteroBiotix is headquartered in Edinburgh, United Kingdom.
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections.
EnteroBiotix is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EnteroBiotix — Funding & Investors." VCBacked, April 29, 2026, https://www.vcbacked.co/company/enterobiotix. Accessed September 30, 2026.
VCBacked. (2026). EnteroBiotix — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/enterobiotix
{{cite web |title=EnteroBiotix — Funding & Investors |url=https://www.vcbacked.co/company/enterobiotix |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated